Read the Rheum (Intro)
"Oh & Are AYYYY"
Love and Lupus
Spondy Senses Tingling
Grab Bag
100

_________ is the leading cause of disability in the U.S.

Arthritis 

100

Morning stiffness is a common symptom of this inflammatory disease. 

RA

100

Common cutaneous manifestations of SLE. 

Malar rash, discoid rash, photosensitivity. 

100

Bilateral sacroiliitis and HLA-B27 antigen are highly associated with this type of spondylitis. 

Ankylosing spondylitis. 

100

Bamboo spine (syndesmophytes) are indicative of this disease. 

Ankylosing spondyloarthritis. 

200

This type of pain (inflammatory or non-inflammatory) worsens with inactivity. 

Inflammatory 

200

The two cardinal features of OA

1) progressive loss of articular cartilage

2) subchondral bone remodeling

200

This demographic makes up 90% of adult SLE cases. 

Females

(Primarily in young women of childbearing age. In addition, SLE occurs more commonly in certain racial and ethnic groups, particularly Black, Asian, and Hispanic populations compared with White populations)

200

Reactive arthritis may occur following infection of these two organ systems. 

Enteric and genitourinary. 

200

Radiating low back pain denotes an inflammatory or non-inflammatory process. 

Inflammatory

300

This solid makes up 10-30% of the joint matrix. It provides tensile strength and stiffness and is anisotropic.

Collagen

300

Marginal erosions, carpal crowding, and ulnar deviation are common xray findings of this disease. 

RA

300

A serious manifestation of SLE occurring in about 50% of patients. Significant cause of mortality and morbidity. 

Lupus nephritis. 

300

This peripheral spondylitis is characterized on film by "pencil-in-cup" deformities. 

Psoriatic spondylitis. 

300

Uveitis is associated with these two conditions. 

Spondyloarthritis and Sarcoidosis

400

Plasma proteins synthesized by the liver in response to inflammation. (Bonus: name the two most common).

Acute Phase Reactants

CRP, ESR

400

Use these pharmacologic agents at the lowest effective dose for the shortest duration possible when treating osteoarthritis. 

NSAIDs

400

The autoantibodies most commonly associated with SLE.

ANA (98%), dsDNA (78%), Extractable Nuclear Antigen Antibodies (anti-Smith, anti-SSA/SSB (Ro/La), anti-RNP)


400

Reiter's triad is common of this disease. 

Reactive arthritis

urethritis, arthritis & conjunctivitis (“can’t pee, can’t see, can’t climb a tree”)

400

Goals of treatment (3) for osteoarthritis

1) Decrease pain

2) Protect joint

3) Maintain function (decrease & prevent disability)

500

Overlap syndrome with features of SLE, scleroderma, and polymyositis and associated with high titers of anti-RNP are given this diagnosis. 

Mixed Connective Tissue Disorder (MCTD)

500

Name the pattern of joint involvement for RA. 

Symmetrical, proximal, non-weight bearing joints. 

MCP, PIP, cervical spine only in advanced seropositive cases

500

Gold standard treatment for patients with SLE.

Hydroxy-chloroquine

500

A patient with Crohn's disease develops oligoarticular and asymmetric arthritis of the knee. His most likely diagnosis is:

Peripheral Enteropathic Arthritis

500

RA is treated early and aggressively with DMARDs. Name the classes of DMARDs and their MOAs. 

csDMARDs (conventional synthetic) - anti-inflammatory & antiproliferative; immunomodulators

tsDMARDs (targeted synthetic) - block JAK-STAT intracellular signaling pathway

bDMARDs (biologic) - TNF inhibitors, monoclonal Abs, T-cell inhibitors, Anti CD20 mAb, IL-6 Inhibitor 

M
e
n
u